| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |